Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-12-18
pubmed:abstractText
It has long been hypothesized that increased adiposity would be associated with decreased vasomotor symptoms during menopause because of conversion of androgens to estrogens in body fat. However, recent thermoregulatory models have postulated that increased adipose tissue would be associated with a greater likelihood of vasomotor symptoms. The authors evaluated these hypotheses in the Study of Women's Health Across the Nation, a multiethnic, community-based observational study of US women transitioning through menopause. The sample included 1,776 women aged 47-59 years with an intact uterus and at least one ovary who completed bioelectrical impedance analysis for assessment of body composition at the sixth annual study visit (2002-2004). Assessments also included reported vasomotor symptoms (hot flashes, night sweats) and serum levels of follicle-stimulating hormone, estradiol, and sex hormone-binding globulin-adjusted estradiol (free estradiol index). Results indicated that a higher percentage of body fat was associated with increased odds of reporting vasomotor symptoms (per standard deviation increase in percent body fat, odds ratio = 1.27, 95% confidence interval: 1.14, 1.42) in age- and site-adjusted models. Associations persisted in fully adjusted models and were not reduced when models included reproductive hormones. These findings support a thermoregulatory model of vasomotor symptoms.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1476-6256
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
78-85
pubmed:meshHeading
pubmed-meshheading:17881385-Adiposity, pubmed-meshheading:17881385-Adult, pubmed-meshheading:17881385-Electric Impedance, pubmed-meshheading:17881385-Estradiol, pubmed-meshheading:17881385-Female, pubmed-meshheading:17881385-Follicle Stimulating Hormone, pubmed-meshheading:17881385-Follow-Up Studies, pubmed-meshheading:17881385-Hot Flashes, pubmed-meshheading:17881385-Humans, pubmed-meshheading:17881385-Immunoassay, pubmed-meshheading:17881385-Incidence, pubmed-meshheading:17881385-Life Style, pubmed-meshheading:17881385-Menopause, pubmed-meshheading:17881385-Middle Aged, pubmed-meshheading:17881385-Multivariate Analysis, pubmed-meshheading:17881385-Prevalence, pubmed-meshheading:17881385-Questionnaires, pubmed-meshheading:17881385-Retrospective Studies, pubmed-meshheading:17881385-Risk Factors, pubmed-meshheading:17881385-Sex Hormone-Binding Globulin, pubmed-meshheading:17881385-Sweating, pubmed-meshheading:17881385-United States, pubmed-meshheading:17881385-Vasomotor System, pubmed-meshheading:17881385-Women's Health
pubmed:year
2008
pubmed:articleTitle
Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
pubmed:affiliation
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA. thurstonrc@upmc.edu
pubmed:publicationType
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural